169 related articles for article (PubMed ID: 26539976)
1. Protopanaxadiol aglycone ginsenoside-polyethylene glycol conjugates: synthesis, physicochemical characterizations, and in vitro studies.
Mathiyalagan R; Kim YJ; Wang C; Jin Y; Subramaniyam S; Singh P; Wang D; Yang DC
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1803-1809. PubMed ID: 26539976
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside compound K-bearing glycol chitosan conjugates: synthesis, physicochemical characterization, and in vitro biological studies.
Mathiyalagan R; Subramaniyam S; Kim YJ; Kim YC; Yang DC
Carbohydr Polym; 2014 Nov; 112():359-66. PubMed ID: 25129755
[TBL] [Abstract][Full Text] [Related]
3. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacokinetic characterization of a pH-sensitive polyethylene glycol ginsenoside CK (PEG-CK) conjugate.
Mathiyalagan R; Subramaniyam S; Kim YJ; Natarajan S; Min JW; Kim SY; Yang DC
Biosci Biotechnol Biochem; 2014; 78(3):466-8. PubMed ID: 25036835
[TBL] [Abstract][Full Text] [Related]
5. Fungal sensitivity to and enzymatic deglycosylation of ginsenosides.
Zhao X; Gao J; Song C; Fang Q; Wang N; Zhao T; Liu D; Zhou Y
Phytochemistry; 2012 Jun; 78():65-71. PubMed ID: 22449289
[TBL] [Abstract][Full Text] [Related]
6. (20S)-Protopanaxadiol Ginsenosides Induced Cytotoxicity via Blockade of Autophagic Flux in HGC-27 Cells.
Han Q; Han L; Tie F; Wang Z; Ma C; Li J; Wang H; Li G
Chem Biodivers; 2020 Jul; 17(7):e2000187. PubMed ID: 32384197
[TBL] [Abstract][Full Text] [Related]
7. A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer.
Musende AG; Eberding A; Wood CA; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Tomlinson Guns ES
Anticancer Drugs; 2012 Jun; 23(5):543-52. PubMed ID: 22481061
[TBL] [Abstract][Full Text] [Related]
8. The in vitro structure-related anti-cancer activity of ginsenosides and their derivatives.
Dong H; Bai LP; Wong VK; Zhou H; Wang JR; Liu Y; Jiang ZH; Liu L
Molecules; 2011 Dec; 16(12):10619-30. PubMed ID: 22183886
[TBL] [Abstract][Full Text] [Related]
9. Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in rats.
Kong LT; Wang Q; Xiao BX; Liao YH; He XX; Ye LH; Liu XM; Chang Q
Fitoterapia; 2013 Apr; 86():48-53. PubMed ID: 23391424
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside 20(S)-Protopanaxadiol Suppresses Viability of Human Glioblastoma Cells via Down-regulation of Cell Adhesion Proteins and Cell-cycle Arrest.
Wanderi C; Kim E; Chang S; Choi C; Choi K
Anticancer Res; 2016 Mar; 36(3):925-32. PubMed ID: 26976980
[TBL] [Abstract][Full Text] [Related]
11. Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins.
Tohda C; Matsumoto N; Zou K; Meselhy MR; Komatsu K
Neuropsychopharmacology; 2004 May; 29(5):860-8. PubMed ID: 15010693
[TBL] [Abstract][Full Text] [Related]
12. The Ginsenoside Derivative 20(S)-Protopanaxadiol Inhibits Solar Ultraviolet Light-Induced Matrix Metalloproteinase-1 Expression.
Han S; Lim TG; Kim JE; Yang H; Oh DK; Yoon Park JH; Kim HJ; Rhee YK; Lee KW
J Cell Biochem; 2017 Nov; 118(11):3756-3764. PubMed ID: 28379603
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic preparation of 20(S, R)-protopanaxadiol by transformation of 20(S, R)-Rg3 from black ginseng.
Liu L; Zhu XM; Wang QJ; Zhang DL; Fang ZM; Wang CY; Wang Z; Sun BS; Wu H; Sung CK
Phytochemistry; 2010 Sep; 71(13):1514-20. PubMed ID: 20576280
[TBL] [Abstract][Full Text] [Related]
14. Modification of ginsenoside saponin composition via the CRISPR/Cas9-mediated knockout of protopanaxadiol 6-hydroxylase gene in
Choi HS; Koo HB; Jeon SW; Han JY; Kim JS; Jun KM; Choi YE
J Ginseng Res; 2022 Jul; 46(4):505-514. PubMed ID: 35818421
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside metabolite 20(S)‑protopanaxadiol promotes neural stem cell transition from a state of proliferation to differentiation by inducing autophagy and cell cycle arrest.
Chen S; He J; Qin X; Luo T; Pandey A; Li J; Liu S; Luo J; Wang Q; Luo Z
Mol Med Rep; 2020 Jul; 22(1):353-361. PubMed ID: 32319663
[TBL] [Abstract][Full Text] [Related]
16. Genetically modified rice produces ginsenoside aglycone (protopanaxadiol).
Han JY; Baek SH; Jo HJ; Yun DW; Choi YE
Planta; 2019 Oct; 250(4):1103-1110. PubMed ID: 31168665
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells.
Li G; Wang Z; Sun Y; Liu K; Wang Z
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):588-92. PubMed ID: 16700822
[TBL] [Abstract][Full Text] [Related]
18. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.
Wang W; Zhao Y; Rayburn ER; Hill DL; Wang H; Zhang R
Cancer Chemother Pharmacol; 2007 Apr; 59(5):589-601. PubMed ID: 16924497
[TBL] [Abstract][Full Text] [Related]
19. [Protopanaxadiol-type ginsenoside hydrolases and their application in the preparation of ginsenoside Compound K: a review].
Yang W; Gu Q; Yu X
Sheng Wu Gong Cheng Xue Bao; 2023 Mar; 39(3):978-992. PubMed ID: 36994566
[TBL] [Abstract][Full Text] [Related]
20. "Nano-Ginseng" for Enhanced Cytotoxicity AGAINST Cancer Cells.
Dai L; Zhu W; Si C; Lei J
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
